Cargando…
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022436/ https://www.ncbi.nlm.nih.gov/pubmed/33823854 http://dx.doi.org/10.1186/s12943-021-01357-z |
| _version_ | 1783674926708817920 |
|---|---|
| author | Reggiani, Francesca Sauta, Elisabetta Torricelli, Federica Zanetti, Eleonora Tagliavini, Elena Santandrea, Giacomo Gobbi, Giulia Damia, Giovanna Bellazzi, Riccardo Ambrosetti, Davide Ciarrocchi, Alessia Sancisi, Valentina |
| author_facet | Reggiani, Francesca Sauta, Elisabetta Torricelli, Federica Zanetti, Eleonora Tagliavini, Elena Santandrea, Giacomo Gobbi, Giulia Damia, Giovanna Bellazzi, Riccardo Ambrosetti, Davide Ciarrocchi, Alessia Sancisi, Valentina |
| author_sort | Reggiani, Francesca |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8022436 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80224362021-04-07 An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma Reggiani, Francesca Sauta, Elisabetta Torricelli, Federica Zanetti, Eleonora Tagliavini, Elena Santandrea, Giacomo Gobbi, Giulia Damia, Giovanna Bellazzi, Riccardo Ambrosetti, Davide Ciarrocchi, Alessia Sancisi, Valentina Mol Cancer Letter to the Editor BioMed Central 2021-04-06 /pmc/articles/PMC8022436/ /pubmed/33823854 http://dx.doi.org/10.1186/s12943-021-01357-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Letter to the Editor Reggiani, Francesca Sauta, Elisabetta Torricelli, Federica Zanetti, Eleonora Tagliavini, Elena Santandrea, Giacomo Gobbi, Giulia Damia, Giovanna Bellazzi, Riccardo Ambrosetti, Davide Ciarrocchi, Alessia Sancisi, Valentina An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma |
| title | An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma |
| title_full | An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma |
| title_fullStr | An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma |
| title_full_unstemmed | An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma |
| title_short | An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma |
| title_sort | integrative functional genomics approach reveals egln1 as a novel therapeutic target in kras mutated lung adenocarcinoma |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022436/ https://www.ncbi.nlm.nih.gov/pubmed/33823854 http://dx.doi.org/10.1186/s12943-021-01357-z |
| work_keys_str_mv | AT reggianifrancesca anintegrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT sautaelisabetta anintegrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT torricellifederica anintegrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT zanettieleonora anintegrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT tagliavinielena anintegrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT santandreagiacomo anintegrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT gobbigiulia anintegrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT damiagiovanna anintegrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT bellazziriccardo anintegrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT ambrosettidavide anintegrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT ciarrocchialessia anintegrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT sancisivalentina anintegrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT reggianifrancesca integrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT sautaelisabetta integrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT torricellifederica integrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT zanettieleonora integrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT tagliavinielena integrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT santandreagiacomo integrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT gobbigiulia integrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT damiagiovanna integrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT bellazziriccardo integrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT ambrosettidavide integrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT ciarrocchialessia integrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma AT sancisivalentina integrativefunctionalgenomicsapproachrevealsegln1asanoveltherapeutictargetinkrasmutatedlungadenocarcinoma |